HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy.

AbstractAIMS:
Whether glucocorticoids induce gastric mucosal injury remains uncertain. We investigated whether very high-dose steroids caused gastric mucosal injury in systemic lupus erythematous (SLE) patients and evaluated the possible risk factors for mucosal injury.
METHODS:
In this prospective paired study, 67 SLE patients who had received pulse methylprednisolone therapy were enrolled. Each patient underwent endoscopic examination and tissue and blood sampling before and after pulse steroid therapy. Mucosal injury was diagnosed if the follow-up injury scale was higher than the initial scale. Examined parameters included Helicobacter pylori infection, cyclooxygenase (COX)-1 and COX-2 activity, and current nonsteroidal anti-inflammatory drug (NSAID) usage including aspirin.
RESULTS:
Eleven (16.4%) of 67 cases who developed gastric mucosal injury after pulse therapy had significantly higher rates of peptic ulcer history, NSAID/aspirin use, lower gastric thromboxane B(2) and prostaglandin E(2) levels when compared with cases without gastric mucosal injury (P < 0.05). Infection by H. pylori was not a risk factor for gastric mucosal injury. Multivariate logistic regression analysis showed that NSAID/aspirin use was the only risk factor for gastric mucosal injury in these patients (odds ratio 26.99, 95% confidence interval 4.91, 148.57, P < 0.0001). Pulse steroid therapy alone did not induce gastric mucosal injury in fifty SLE patients without taking any NSAID/aspirin.
CONCLUSIONS:
Use of NSAIDs/aspirin, but not H. pylori infection, increases gastric mucosal injury in SLE patients receiving pulse methylprednisolone therapy. Very high-dose steroids de novo seem not to induce gastric mucosal injury in these patients. A larger case-controlled study enrolling a heterogeneous population is needed to clarify the role of glucocorticoids in gastric mucosal injury.
AuthorsJiing-Chyuan Luo, Full-Young Chang, Tseng-Shing Chen, Yee-Yung Ng, Han-Chieh Lin, Ching-Liang Lu, Chih-Yen Chen, Hsiao-Yi Lin, Shou-Dong Lee
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 68 Issue 2 Pg. 252-9 (Aug 2009) ISSN: 1365-2125 [Electronic] England
PMID19694746 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Methylprednisolone Hemisuccinate
  • Aspirin
Topics
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects)
  • Aspirin (administration & dosage, adverse effects)
  • Epidemiologic Methods
  • Female
  • Gastric Mucosa (drug effects, injuries)
  • Helicobacter Infections (chemically induced, complications)
  • Humans
  • Male
  • Methylprednisolone Hemisuccinate (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: